Periodontal Therapy and Genitourinary Inflammation in Patients With Prostatitis and Recurrent Urinary Tract Infections
PERIO-PSA
Impact of Non-surgical Periodontal Therapy on Prostate-specific Antigen Levels and Urinary Tract Infection Recurrence: a Randomized Controlled Clinical Trial
2 other identifiers
interventional
60
1 country
1
Brief Summary
This randomized controlled clinical trial evaluates the impact of non-surgical periodontal therapy on systemic inflammatory markers in patients with chronic prostatitis or recurrent urinary tract infections. Emerging evidence suggests a possible association between periodontal inflammation and genitourinary conditions. A total of 60 male participants diagnosed with periodontitis and either chronic prostatitis or recurrent urinary tract infections were randomly assigned to one of three groups: non-surgical periodontal therapy, oral hygiene instruction only, or no periodontal treatment. The primary outcomes were changes in serum prostate-specific antigen (PSA) levels and the frequency of positive urine cultures over a 120-day follow-up period. The study aims to investigate whether periodontal treatment may reduce systemic inflammatory burden and improve genitourinary clinical parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 22, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedMarch 13, 2026
March 1, 2026
1.2 years
February 22, 2026
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in serum prostate-specific antigen (PSA) levels
Difference in serum prostate-specific antigen (PSA) levels measured in ng/mL between baseline and 120 days after intervention.
Baseline to 120 days
Secondary Outcomes (1)
Change in frequency of positive urine cultures
Baseline to 120 days
Study Arms (3)
Non-Surgical Periodontal Therapy
EXPERIMENTALParticipants received full-mouth scaling and root planing combined with oral hygiene instruction.
Oral Hygiene Instruction
ACTIVE COMPARATORParticipants received standardized oral hygiene instructions without mechanical periodontal treatment.
Control
NO INTERVENTIONParticipants did not receive periodontal treatment during the 120-day follow-up period.
Interventions
Full-mouth scaling and root planing performed under local anesthesia using ultrasonic and hand instruments, completed within two sessions over a one-week period. Participants also received standardized oral hygiene instructions including tooth brushing technique and interdental cleaning guidance.
Standardized oral hygiene instructions including tooth brushing technique, use of interdental cleaning devices, and reinforcement of plaque control measures, without mechanical periodontal instrumentation.
Eligibility Criteria
You may qualify if:
- Male participants aged 18 years or older
- Diagnosis of chronic prostatitis (NIH category III) or recurrent urinary tract infections
- Diagnosis of periodontitis according to the 2017 World Workshop classification
- Ability to provide written informed consent
You may not qualify if:
- Antibiotic therapy within the previous 3 months
- Systemic immunosuppressive disorders
- History of prostate cancer
- Ongoing periodontal treatment
- Severe systemic diseases affecting inflammatory status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Salamanca
Salamanca, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention, blinding of participants and care providers was not feasible.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Department
Study Record Dates
First Submitted
February 22, 2026
First Posted
February 27, 2026
Study Start
January 1, 2024
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share